Effect of Grapefruit on QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome

Key facts

Sponsor

Tel-Aviv Sourasky Medical Center

Principal Investigator

Ehud Chorin, MD

Tel Aviv MC

Intervention

Moxifloxacin(drug)

Enrollment

25 enrolled

Eligibility

18-99 years · All sexes

Timeline

2016 – 2019

Study locations (1)

• Sourasky medical center (Ichilov), Tel Aviv, Israel

Collaborators

Tel Aviv Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Congenital long QT syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT06887387
  Wearable Devices for Patient Monitoring in Long QT Syndrome
  Queen Mary University of London
• ENROLLING BY INVITATIONNANCT07233421
  Frequency of Hypoglycemia in Children With Beta-blocker Treated Long QT-syndrome
  Helsinki University Central Hospital
• RECRUITINGNANCT04336644
  Continuous Versus Intermittent cARdiac Electrical moNitorinG
  Washington University School of Medicine
• RECRUITINGNANCT05348564
  Comparing Direct vs Indirect Methods for Cascade Screening
  University of Maryland, Baltimore
• RECRUITINGNCT06087367
  Building of a Diagnostic/Prognostic Database for Human ERG Variant Effects
  Nantes University Hospital

See all trials for Congenital long QT syndrome →